Skip to main content

Post-operative Pain, Acute

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
Auricular percutaneous nerve field stimulatorN/A1 trial
Active Trials
NCT06434714Withdrawn0Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
iNova PharmaceuticalsAuricular percutaneous nerve field stimulator

Clinical Trials (1)

NCT06434714iNova PharmaceuticalsAuricular percutaneous nerve field stimulator

Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator

Start: Jun 2024Est. completion: Sep 20250
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.